Stockscreener 앱 받기
68.76
0.51%
-0.3504
시간 외 거래:
68.76
0.0004
+0.00%
전일 마감가:
$69.11
열려 있는:
$68.7596
하루 거래량:
2
Relative Volume:
0.01
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.14%
1개월 성능:
+1.87%
6개월 성능:
+20.89%
1년 성능:
+0.00%
1일 변동 폭
$68.76
$68.76
1주일 범위
$67.81
$69.81
52주 변동 폭
$50.43
$69.81
Gsk Plc Adrhedged Stock (GSKH) Company Profile
GSKH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GSKH
Gsk Plc Adrhedged
|
68.76 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
337.56 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
685.69 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
689.11 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.19 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
625.48 | 124.43B | 0 | 0 | 0 | 0.00 |
Gsk Plc Adrhedged 주식(GSKH)의 최신 뉴스
Bharat Forge Limited (BHARATFORG)’s Trend in 2025 - earlytimes.in
How GSK plc ADRhedged stock performs in rising dollar environment2025 Analyst Calls & Free Community Supported Trade Ideas - Newser
Is GSK plc ADRhedged stock dividend yield sustainable2025 Trade Ideas & Stock Portfolio Risk Management - Newser
What momentum indicators show for GSK plc ADRhedged stock2025 Analyst Calls & Growth Focused Entry Reports - Newser
What drives GSK plc ADRhedged stock priceFlag and Pennant Patterns & Discover Your Financial Freedom Formula - earlytimes.in
How GSK plc ADRhedged stock trades during market volatilityJuly 2025 Pullbacks & Weekly High Return Opportunities - newser.com
Is GSK plc ADRhedged stock overvalued by current metrics2025 Top Gainers & Free Weekly Watchlist of Top Performers - newser.com
Is GSK plc ADRhedged stock oversold or undervaluedQuarterly Market Summary & Reliable Breakout Forecasts - newser.com
Can GSK plc ADRhedged stock rebound after recent weaknessIPO Watch & Free Technical Pattern Based Buy Signals - newser.com
European Equities Close Mostly Higher in Wednesday Trading; Eurozone Inflation Declines in October - 富途牛牛
GSK Partners With LTZ Therapeutics to Develop Myeloid Cell Engagers for Oncology - 富途牛牛
GSK, LTZ Therapeutics to Collaborate on Myeloid Cell Engagers for Oncology - 富途牛牛
Is Hafnia Limited Common Shares stock protected from inflationJuly 2025 Fed Impact & Consistent Profit Alerts - newser.com
Is GSK plc ADRhedged stock a buy on dipsLayoff News & Fast Momentum Entry Tips - newser.com
How GSK plc ADRhedged stock performs in rate cut cyclesMarket Trend Review & Community Shared Stock Ideas - newser.com
Applying chart zones and confluence areas to GSK plc ADRhedgedForecast Cut & AI Forecast for Swing Trade Picks - newser.com
How GSK plc ADRhedged stock benefits from tech adoptionPortfolio Return Report & Fast Momentum Stock Entry Tips - newser.com
Can GSK plc ADRhedged stock hit record highs againTrade Risk Assessment & Growth Focused Stock Pick Reports - Fundação Cultural do Pará
Can GSK plc ADRhedged stock withstand economic slowdownPrice Action & Scalable Portfolio Growth Ideas - Fundação Cultural do Pará
Why Southwest Airlines Company stock could be next leaderInsider Selling & AI Enhanced Trading Alerts - newser.com
Pattern recognition hints at GSK plc ADRhedged upsideJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
GSKH ETF | GSK plc ADRhedged - GuruFocus
Should elderly individuals with chronic illnesses receive vaccines? GSK explores new frontiers in immune prevention. - 富途牛牛
Is GSK plc ADRhedged stock a dividend growth opportunityJuly 2025 Fed Impact & Short-Term Trading Alerts - Fundação Cultural do Pará
Strategies to average down on GSK plc ADRhedgedRisk Management & Weekly Chart Analysis and Trade Guides - newser.com
Gsk Plc Adrhedged (GSKH) 재무 분석
Gsk Plc Adrhedged (GSKH)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.11%
0.45%
자본화:
|
볼륨(24시간):